Dear Editor, Ehrlichiosis is an important infection that is considered a newly emerging zoonosis. The infection is carried by arthropods from dogs to human beings and becomes a great concern at present.[1] In HIV-infected patients, the severe infection can be seen due to impaired immune status[2] and can be fatal.[3] Here, the authors investigated the seropositivity for ehrlichiosis in 200 anonymous samples from HIV-infected cases (as laboratory wastes from a medical center). The serological analysis is based on an indirect immunofluorescence assay for detecting antibody reactivity. The protocol of this study is approved by a local ethical committee. The seropositive rate is calculated as "(number of test positive samples/number of all samples) ×100" and presented as percentage. In addition, 95% confidence interval (CI) of derived seropositive rate is also calculated. According to this study, there is only one seropositive sample giving the prevalence equal to 0.5% (95% CI = 0.07%–0.53%). Of interest, this is the first world report on the seroprevalence of this infectious disease among HIV-infected cases. At present, ehrlichiosis is classified as an important emerging zoonosis[4] and the infections in HIV-infected cases are already reported.[2,5] Hence, ehrlichiosis might be an important problem for anyone with HIV infection. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Mungmunpuntipantip et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: